Feb 11, 2022 / IndustryNewsGlobal / The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Cephalosporin Market.
It was estimated prior to this unanticipated outbreak that the Cephalosporin Market projected to grow from USD 13.89 billion in 2020 to USD 16.35 billion by 2026 at a CAGR of over 2.8% during the forecast period. Cephalosporin is a bactericidal and β-lactam antibiotic mainly derived It inhibits enzymes in the cell wall of the susceptible bacteria and disrupts the cell synthesis. It inhibits enzymes in the cell wall of the susceptible bacteria and disrupts the cell synthesis. Cephalosporin is majorly designated for prophylaxis as well as for the treatment of infections caused by bacteria
The growing prevalence of infectious diseases and the increase in funding for the development of antibiotics are some of the key factors bolstering the product demand. Additionally, the surge in R & D activities for the production of combination drugs and the rising demand for antibacterial further augmenting the market. growth. Moreover, the discovery of innovative prospect molecules and the introduction of novel combination therapies to treat antibiotic-resistant infections are likely to provide lucrative opportunities to the industry participants. However, the side effects of cephalosporin are likely to hinder the industry expansion.
Segment . Analysis
By type, the cephalosporin market has been segmented into branded and generic.
• Under these, the generic segment held a considerable market share in 2020 and is likely to register the fastest CAGR during the review period.
• This is mainly attributed to the easy availability of drugs at a lower cost when compared to branded drugs.
• Also
By region, the Asia Pacific market witnessed the highest market share in 2020 and is estimated to grow at a substantial CAGR during the assessment period. •
This is mainly ascribed to the rise in consumption of cephalosporin, upsurge in demand for over-the-counter drugs, easier availability, and increasing bacterial infections in the Asia Pacific.
• Moreover, growing healthcare expenditure and improving standards of living with large population growth further boosts the regional growth.
Key Players:
Key players operating in the global cephalosporin market are-
• Aristo Pharmaceuticals Ltd (India),
• Baxter International (The US),
• F. Hoffmann-La Roche AG (Switzerland),
• GlaxoSmithKline PLC (UK),
• Lupin Pharmaceuticals Inc. (India),
• Macleods Pharmaceuticals Ltd (India),
• Mankind Pharma (India),
• Merck & Co. Inc. (The US),
• Pfizer Inc. (The US),
• Teva Pharmaceutical Industries Ltd. (Israel).
Features of the Report

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research's internal database and statistical tools. :
• Market structure: Overview, industry life cycle analysis, supply chain analysis
• COVID-19 Impact Assessment
• Market environment analysis: Growth drivers and constraints, Porter's five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors
Know more about Stratview Research:
Stratview Research is a global market research company and is known to offer custom research reports in varied fields Our team makes sure to have deep such as aerospace & Defense, Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. research about the topics so that the most useful insights can be delivered to the professionals.
Need a detailed report? Get in touch with us:
Stratview Research
E-mail: sales@stratviewresearch.com
Direct: + 1-313-307-4176